Duration of Anticoagulation Therapy in Patients with Genetic Inherited Thrombophilia Cover

.blurhash-client-img { display: none !important; }

Duration of Anticoagulation Therapy in Patients with Genetic Inherited Thrombophilia

Volume 43 (2022): Issue 2 (July 2022)

By: Ivica Bojovski, Svetlana Stankovic, Aleksandar Petlichkovski and Marijan Bosevski

Open Access

|Jul 2022

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/prilozi-2022-0016 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345

Journal RSS Feed

Language: English

Page range: 33 - 40

Published on: Jul 13, 2022

Published by: Macedonian Academy of Sciences and Arts

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

deep vein thrombosis,

pulmonary embolism,

anticoagulation therapy,

genetic investigation,

Related subjects:

Basic medical science,

History and ethics of medicine,

Clinical medicine,

Clinical medicine, other,

Social sciences,

Education, other

© 2022 Ivica Bojovski, Svetlana Stankovic, Aleksandar Petlichkovski, Marijan Bosevski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 43 (2022): Issue 2 (July 2022)Next article